ホーム>>Signaling Pathways>> Neuroscience>> Pain Research>>Ketorolac (calcium salt)

Ketorolac (calcium salt)

カタログ番号GC47528

ケトロラック (RS37619) ヘミカルシウムは非ステロイド性抗炎症薬 (NSAID) であり、非選択的な COX 阻害剤として作用し、COX-1 の IC50 は 20 nM、COX-2 の IC50 は 120 nM です。

Products are for research use only. Not for human use. We do not sell to patients.

Ketorolac (calcium salt) 化学構造

Cas No.: 167105-81-9

サイズ 価格 在庫数 個数
100 mg
$77.00
在庫あり
250 mg
$165.00
在庫あり
500 mg
$308.00
在庫あり
1 g
$502.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) and a non-selective COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2).1 It prevents increases in paw swelling, increases paw withdrawal latency in a hot-plate test, and decreases prostaglandin E2 (PGE2) levels in paw tissue in a mouse model of carrageenan-induced inflammation when administered at a dose of 30 mg/kg. Ketorolac is a racemic mixture containing the active (S)-ketorolac and inactive (R)-ketorolac enantiomers. Formulations containing ketorolac have been used to manage postoperative pain and as ophthalmic solutions to treat ocular pain and inflammation.

1.Zhang, Y., Shaffer, A., Portanova, J., et al.Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 productionJ. Pharmacol. Exp. Ther.283(3)1069-1075(1997)

レビュー

Review for Ketorolac (calcium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ketorolac (calcium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.